FF-21101-Y-90

N/A

Report date: 2025/11/21 17:15:19

Base Information

Drug NameFF-21101-Y-90
Drug Alias NameFF-21101-Y-90PPMX-T002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agent +[5] 
Mechanisms of ActionIonising radiation emittersCadherin 3 inhibitors
TargetsCadherin 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFujifilm Holdings Corp
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncFujifilm Pharmaceuticals U.S.A. IncFujifilm Toyama Chemical Co Ltd
Inactive CompaniesFujifilm Corp
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A